News >

Pegfilgrastim Plus Plinabulin Reduces Chemo-Induced Neutropenia in TAC-Treated Patients

Jessica Hergert
Published: Friday, Jan 31, 2020

Douglas W. Blayney, MD, a professor of medicine (oncology) at Stanford Medical Center

Douglas W. Blayney, MD

The combination of pegfilgrastim (Neulasta) and plinabulin demonstrated a reduction in chemotherapy-induced neutropenia (CIN) versus pegfilgrastim alone in patients treated with docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy, according to results from the phase II trial Study 106.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication